Peptides / Growth hormone axis
Synthetic analog · 29 amino acids · 3,367.9 Da
Mod GRF (1-29) (CJC-1295 without DAC)
Not approvedBanned in sport
CJC-1295 no DAC, also called Mod GRF (1-29), is a synthetic 29-amino-acid form of growth hormone-releasing hormone without the DAC group. It is not approved and is banned in sport, and few published studies test it. PepBank shows no results on CJC-1295 no DAC from studies in people, animals, the lab or computer predictions. Data as of 2026-10-30.
Also known as CJC-1295 (free base), CJC-1295 without DAC, Mod GRF (1-29), Modified GRF 1-29, Tetra-substituted GRF 1-29, tetrasubstituted hGRF(1-29) and 1 more
CJC-1295 without DAC is also in 1 blend: CJC-1295 + ipamorelin.
29 amino acids, from first to last5 changed amino acids
Evidence level: No study results yetPepBank has no study results for CJC-1295 no DAC yet.
Results in people
0
0% of 0 results
Results in animals
0
0% of 0 results
Results in lab cells
0
0% of 0 results
From computer models
0
0% of 0 results
Overview
Mod GRF (1-29) (CJC-1295 without DAC) at a glance
| What it is | Synthetic analog, 29 amino acids |
|---|---|
| Approval | Not approved for any use |
| In sport | Banned in sport (WADA S2.2.4) |
| Studies | No study results for CJC-1295 no DAC yet |
| Clinical trials | None registered |
| Community use | Wiki-reported Standard GHRH Protocol |
The science
What is CJC-1295 no DAC?
Synthetic 29-residue GHRH analogue without the DAC group. No FDA or EMA approval was found for this substance.
29
Amino acids in one chain
Mod GRF (1-29) (CJC-1295 without DAC) structure and chemistry
The key facts about the molecule. Long codes are in the closed section below.
Sequence, 29 amino acidsFrom the first amino acid to the last
Y1A−DAI5FTQSY10+R+KVLA15QLSA+R20+KLLQ−D25ILS+R
Darker means more water-repelling+ and − show charge in the bodyOutlined: changed amino acid
Structure
Mod GRF (1-29) (CJC-1295 without DAC) is a synthetic analog of 29 amino acids, with no ring, 5 changed amino acids.
Formula
C152H252N44O42
Molecular weight
3,367.9 g/mol
CAS number
446036-97-1
Target
Growth hormone-releasing hormone receptor (gene GHRHR): agonistEvidence: proposed
Development
Highest phase: no known clinical development.
Identifiers
PubChem 56841945
Full sequence, SMILES and InChIKey
Three-letter sequenceH-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
InChIKeyXOZMWINMZMMOBR-HRDSVTNWSA-N
SMILESCC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N
The evidence
What CJC-1295 no DAC studies show
Results grouped by what the studies measured. Each card shows where its results come from.
No study results yetPepBank has no study results for CJC-1295 no DAC yet.
Key CJC-1295 no DAC studies
No study of CJC-1295 no DAC has results in PepBank yet.
CJC-1295 no DAC clinical trials
ClinicalTrials.gov lists no trial of CJC-1295 no DAC. A trial under another name may exist.
Status and safety
Is CJC-1295 no DAC approved?
FDA
United States
Not approvedNo approved medicine contains it.
EMA
European Union
Not approvedNo approved medicine contains it.
WADA
Sport
BannedOn the 2026 Prohibited List, section S2.2.4.
No. Not approved for any use. The sources we use show no clinical development. They show no approval at the FDA, the EMA or elsewhere (as of 13 Oct 2026). Banned in sport (WADA S2.2.4).
Laws and labels change, so check the regulator for the current status.
CJC-1295 no DAC side effects and safety
PepBank has no safety result from studies of CJC-1295 no DAC yet. That does not mean CJC-1295 no DAC is safe.
From the community
How people use it
What people report online. It comes from forums and guides, not from studies.
Community-reported. Not tested in trials.
An automated community wiki reports this protocol. Original user reports were not verified. The report does not establish safety or efficacy.
Reported routines and cautions
What people use it for
- Wiki-reported Standard GHRH ProtocolS1
Reported regimens
| Context | Route | Amount | How often | How long | Agreement | Sources |
|---|---|---|---|---|---|---|
| Wiki-reported Standard GHRH Protocol | subcutaneous | 100 to 200 mcg per dose | 1-3 times daily | 8-12 weeks | Single automated wiki source. Original community reports were not verified. | S1 |
Community sources
- S1CJC-1295 without DAC community protocols (opens in a new tab)www.peptideprotocolwiki.com
- S2How This Site Works — Methodology (opens in a new tab)www.peptideprotocolwiki.com
Gaps
Original user reports, actual use, product identity and product purity were not independently verified. No official manufacturer label regimen was found.
Questions and more
Ask a question about CJC-1295 no DAC
The answer links to every study it uses.
Sources
- Database: PepBank data for CJC-1295 no DAC (data version 308560)
- Regulator: FDA status record
- Regulator: EMA status record
- Regulator: WADA status record
- Community: community sources (forums and guides), as summarized in the PepBank community file
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.
Ask your AI about CJC-1295 no DAC
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).